Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Equity Ratio (2017 - 2025)

Puma Biotechnology (PBYI) has disclosed Equity Ratio for 9 consecutive years, with 0.6 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio rose 39.54% year-over-year to 0.6, compared with a TTM value of 0.6 through Dec 2025, up 39.54%, and an annual FY2025 reading of 0.6, up 39.54% over the prior year.
  • Equity Ratio was 0.6 for Q4 2025 at Puma Biotechnology, up from 0.57 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.6 in Q4 2025 and bottomed at 0.05 in Q3 2021.
  • Average Equity Ratio over 5 years is 0.23, with a median of 0.17 recorded in 2023.
  • The sharpest move saw Equity Ratio plummeted 2688.3% in 2021, then skyrocketed 1001.41% in 2022.
  • Year by year, Equity Ratio stood at 0.01 in 2021, then surged by 1001.41% to 0.1 in 2022, then surged by 138.24% to 0.23 in 2023, then soared by 86.28% to 0.43 in 2024, then surged by 39.54% to 0.6 in 2025.
  • Business Quant data shows Equity Ratio for PBYI at 0.6 in Q4 2025, 0.57 in Q3 2025, and 0.54 in Q2 2025.